Direct Relationship Between Levels of TNF-alpha Expression and Endothelial Dysfunction in Reperfusion Injury
Overview
Affiliations
We previously found that myocardial ischemia/reperfusion (I/R) initiates expression of tumor necrosis factor-alpha (TNF) leading to coronary endothelial dysfunction. However, it is not clear whether there is a direct relationship between levels of TNF expression and endothelial dysfunction in reperfusion injury. We studied levels of TNF expression by using different transgenic animals expressing varying amounts of TNF in I/R. We crossed TNF overexpression (TNF(++/++)) with TNF knockout (TNF(-/-)) mice; thus we have a heterozygote population of mice with the expression of TNF "in between" the TNF(-/-) and TNF(++/++) mice. Mouse hearts were subjected to 30 min of global ischemia followed by 90 min of reperfusion and their vasoactivity before and after I/R was examined in wild type (WT), TNF(-/-), TNF(++/++) and TNF heterozygote (TNF(-/++), cross between TNF(-/-) and TNF(++/++)) mice. In heterozygote TNF(-/++) mice with intermediate cardiac-specific expression of TNF, acetylcholine-induced or flow-induced endothelial-dependent vasodilation following I/R was between TNF(++/++) and TNF(-/-) following I/R. Neutralizing antibodies to TNF administered immediately before the onset of reperfusion-preserved endothelial-dependent dilation following I/R in WT, TNF(-/++) and TNF(++/++) mice. In WT, TNF(-/++) and TNF(++/++) mice, I/R-induced endothelial dysfunction was progressively lessened by administration of free-radical scavenger TEMPOL immediately before initiating reperfusion. During I/R, production of superoxide (O(2) (.-)) was greatest in TNF(++/++) mice as compared to WT, TNF(-/++) and TNF(-/-) mice. Following I/R, arginase mRNA expression was elevated in the WT, substantially elevated in the TNF(-/++) and TNF(++/++) mice and not affected in the TNF(-/-) mice. These results suggest that the level of TNF expression determines arginase expression in endothelial cells during myocardial I/R, which is one of the mechanisms by which TNF compromises coronary endothelial function in reperfusion injury.
Moura-Maia M, Brill B, Paula-Vieira R, Ramos-Gomes N, Melamed D, Silva-Reis A Nutrients. 2024; 16(21).
PMID: 39519510 PMC: 11547299. DOI: 10.3390/nu16213677.
Basuguy E, Ozkorkmaz E Acta Clin Croat. 2024; 62(3):437-446.
PMID: 39310681 PMC: 11414001. DOI: 10.20471/acc.2023.62.03.5.
Gunay Y, Karagozlu F, Gemici S, Yilmaz S, Sahin S, Barut K Eur J Pediatr. 2024; 183(7):3137-3145.
PMID: 38668795 PMC: 11192814. DOI: 10.1007/s00431-024-05570-y.
Extracellular vesicles in cardiovascular disease: Biological functions and therapeutic implications.
Han C, Yang J, Sun J, Qin G Pharmacol Ther. 2021; 233:108025.
PMID: 34687770 PMC: 9018895. DOI: 10.1016/j.pharmthera.2021.108025.
Minimizing Ischemia Reperfusion Injury in Xenotransplantation.
Patel P, Connolly M, Coe T, Calhoun A, Pollok F, Markmann J Front Immunol. 2021; 12:681504.
PMID: 34566955 PMC: 8458821. DOI: 10.3389/fimmu.2021.681504.